| Withdrawn | CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosu NCT06752876 | Caribou Biosciences, Inc. | Phase 1 |
| Not Yet Recruiting | Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress NCT06999109 | Duke University | N/A |
| Not Yet Recruiting | Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus. NCT07483541 | Investigación en Hemofilia y Fisioterapia | — |
| Recruiting | The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. NCT06426316 | University Hospital, Clermont-Ferrand | N/A |
| Active Not Recruiting | Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) NCT06294236 | Sana Biotechnology | Phase 1 |
| Completed | Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus NCT06161363 | University Hospital, Toulouse | — |
| Terminated | A Study of Imvotamab in Severe Systemic Lupus Erythematosus NCT06041568 | IGM Biosciences, Inc. | Phase 1 |
| Completed | Exploring Accessible Beauty for Individuals With Upper Extremity Deficits NCT05945784 | Casa Colina Hospital and Centers for Healthcare | — |
| Unknown | The Living With a Long-Term Condition Study NCT06072287 | King's College London | — |
| Recruiting | Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells NCT03673748 | Red de Terapia Celular | Phase 2 |
| Completed | Transition to Adulthood Through Coaching and Empowerment in Rheumatology NCT05545839 | McMaster University | N/A |
| Completed | The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients NCT05921058 | Universitas Sebelas Maret | Phase 1 / Phase 2 |
| Recruiting | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases NCT05251415 | University Hospital, Toulouse | — |
| Enrolling By Invitation | Methyl-donor Nutrient Supplementation and Methylation Profile in Lupus Patients With Obesity NCT05097365 | University of Sao Paulo | N/A |
| Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic NCT05098600 | Faculty Hospital Kralovske Vinohrady | — |
| Recruiting | Trial of Belimumab in Early Lupus NCT03543839 | Northwell Health | Phase 4 |
| Completed | Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients NCT04089930 | Tuen Mun Hospital | — |
| Unknown | Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals NCT04449653 | Progentec Diagnostics, Inc. | — |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Lupus NCT04213690 | ProgenaBiome | — |
| Completed | Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis NCT04128579 | Equillium | Phase 1 |
| Unknown | Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umb NCT03562065 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Suspended | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469 | ProgenaBiome | — |
| Completed | Psycho-social Consequences of Systemic Lupus Erythematosus NCT03913754 | Assistance Publique Hopitaux De Marseille | — |
| Unknown | Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic NCT04018222 | Progentec Diagnostics, Inc. | — |
| Completed | Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus NCT03421184 | University Hospital, Bordeaux | N/A |
| Completed | Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythem NCT03504540 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Completed | A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE NCT03098823 | Ampel BioSolutions, LLC | Phase 4 |
| Unknown | Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization NCT03142412 | DxTerity Diagnostics | — |
| Completed | Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) NCT03253666 | Harvard School of Public Health (HSPH) | — |
| Unknown | Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic NCT02891213 | CHU de Reims | — |
| Terminated | Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (S NCT02080195 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 / Phase 2 |
| Completed | Analysis of B Cells From Autoimmune Individuals NCT02747277 | University of Colorado, Denver | — |
| Completed | Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Eryth NCT02455089 | University Hospital, Grenoble | N/A |
| Unknown | PatientSpot Formerly Known as ArthritisPower NCT03840928 | Global Healthy Living Foundation | — |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic NCT01686555 | AbbVie (prior sponsor, Abbott) | Phase 1 |
| Completed | Photoprovocation Testing in Subjects With Cutaneous Lupus NCT01516788 | University of Pennsylvania | N/A |
| Completed | Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus NCT01904812 | Centre Hospitalier Universitaire Dijon | N/A |
| Recruiting | Cutaneous Lupus Registry NCT01266915 | University of Texas Southwestern Medical Center | — |
| Completed | Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity NCT00029926 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — |